切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (03) : 3 -9. doi: 10.3877/cma.j.issn.1674-0807.2007.03.002

专家论坛

乳腺癌保乳术后放射治疗进展
于金明1, 李建彬1,()   
  1. 1.250117 济南,山东省肿瘤医院放射治疗科
  • 收稿日期:2007-04-09 出版日期:2007-06-01
  • 通信作者: 李建彬

Advances in radiation therapy following breast conserving therapy for breast cancer

Jin-ming YU, Jian-bin LI()   

  • Received:2007-04-09 Published:2007-06-01
  • Corresponding author: Jian-bin LI
引用本文:

于金明, 李建彬. 乳腺癌保乳术后放射治疗进展[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(03): 3-9.

Jin-ming YU, Jian-bin LI. Advances in radiation therapy following breast conserving therapy for breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(03): 3-9.

表1 保乳术后放射治疗与否对乳腺癌复发及患者生存率的影响
表2 保乳手术加放射治疗与乳房切除术对患者生存的影响
表3 组织间插植放射治疗作为保留乳房术后放射治疗单一模式的结果报告
[1]
Veronesi U,Luini A,Galimberti V,et al.Conservation approaches for the management of stage Ⅰ/Ⅱ carcinoma of the breast.Milan Cancer Institute Trials.World J Surg,1994,18:70-75.
[2]
Liljegren G.Is postoperative radiotherapy after breast conserving surgery always mandatory?A review of andomized controlled trials.Scand J Surg,2002,91:251-254.
[3]
Clark R M,Whelan T,Levine M,et al.Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer:an update.Ontario Clinical Oncology Group.J Natl Cancer Inst,1996,88:1659-1664.
[4]
Fisher B,Anderson S,Redmond C K,et al.Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.N Engl Jmed,1995,333:1456-1461.
[5]
Fisher B,Jeong J H,Dignam J,et al.Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage Ⅰ breast cancer.J NatlCancer Inst Monogr,2001,(30):62-66.
[6]
Clarke M,Collins R,Darby S,et al.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:an overview of the andomized trials.Lancet,2005,366:2087-2106.
[7]
Magee B,Swindell R,Harris M,et al.Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy:results from a andomized trial.Radiother Oncol,1996,39:223-227.
[8]
Voogd A C,Nielsen M,Peterse J L,et al.Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage Ⅰ and Ⅱ breast cancer:pooled results of two large European randomized trials.J Clin Oncol,2001,19:1688-1697.
[9]
Veronesi U,Cascinelli N,Mariani L,et al.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med,2002,347:1227-1232.
[10]
Arriagada R,Le M G,Rochard F,et al.Conservative treatment versus mastectomy in early breast cancer:patterns of failure with 15 years of follow-up data.Institut Gustave-Roussy Breast Cancer Group.J Clin Oncol,1996,14:1558-1564.
[11]
Poggi M M,Danforth D N,Sciuto L C,et al.Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy:the National Cancer Institute Randomized Trial.Cancer,2003,98:697-702.
[12]
van Dongen J A,Voogd A C,Fentiman I S,et al.Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy:European Organization for Research and Treatment of Cancer 10801 trial.J NatlCancer Inst,2000,92:1143-1150.
[13]
Blichert Toft M,Rose C,Andersen J A,et al.Danish randomized trial comparing breast conservation therapy with mastectomy:six years of life-table analysis.Danish Breast Cancer Cooperative Group.J NatlCancer Inst Monogr,1992,(11):19-25.
[14]
Kuerer H M,Julian T G,Strom E A,et al.accelerated partal breast irradiation after conservative surgery for breast cancer.Ann Surg,2004,239:338-351.
[15]
Solin L J,Kurtz J,Fourquet A,et al.Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.J Clin Oncol,1996,14:754-763.
[16]
Julien J P,Bijker N,Fentiman I S,et al.Radiotherapy in breastconserving treatment for ductal carcinoma in situ:first results of EORTC randomized phase Ⅲ trial 10853.EORTC Breast Cancer Cooperative Group and EORTC Radiotherpy Group.Lancet,2000,355:528-533.
[17]
Fisher B,Dignam J,Wolmark N,et al.Lumpectomy and radiation therapy for the treatment of intraductal breast cancer:findings from National Surgical Adjuvant Breast and Bowel Project B-17.J Clin Oncol,1998,16:441-452.
[18]
Chua B,Olivotto L A,Donald J C,et al.Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia.Can J Surg,2003,46:273-278.
[19]
Krueger E A,Fraass B A,Pierce L J.Clinical aspects of inten sity-modulated radiotherapy in the treatment of breast cancer.Semin Radiat Oncol,2002,12:250-259.
[20]
Potters L,Steinberg M,Wallner P,et al.How one defines intensity-modulated radiation therapy.Int J Radiat Oncol Biol Phys,2003,56:609-610.
[21]
Glatstein E.The return of the snake oil salesmen.Int J Radiat Oncol Biol Phys,2003,55:561-562.
[22]
Glatstein E.Intensity-modulated radiation therapy:the inverse,the converse,and the perverse.Semin Radiat Oncol,2002,12:272-281.
[23]
Bortfeld T.Optimized planning using physical objectives and constraints.Semin Radiat Oncol,1999,9:20-34.
[24]
Kestin L L,Sharpe M B,Frazier R C,et al.Intensity modulation to improve dose uniformity with tangential breast radiotherapy:initial clinical experience.Int J Radiat Oncol Biol Phys,2000,48:1559-1568.
[25]
Krueger E A,Coselmon M,Pierce L,et al.Accelerated whole breast radiotherapy with a concomitant boost using a cone IMRT(cIMRT)technique.Int J Radiat Oncol Biol Phys,2003,57:S364.
[26]
Song Y,Peng P,Boyer A L,et al.Concurrent boost using forward multiple-segment planning and step-and-shoot delivery:a novel technique of breast-conserving radiation therapy.Int J Radiat Oncol Biol Phys,2003,57:S368.
[27]
Teh B S,Lu H H,Sobremonte S,et al.The potential use of intensity modulated radiotherapy(IMRT)in women with pectus excavatum desiring breast-conserving therapy.Breast J,2001,7:233-239.
[28]
Fentiman I S,Poole C,Tong D,et al.Inadequacy of iridium implant as sole radiation treatment for operable breast cancer.Eur J Cancer,1996,32A:608-611.
[29]
King T A,Bolton J S,Kuske R R,et al.Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2)breast cancer.Am J Surg,2000,180:299-304.
[30]
Krishnan L,Jewell W R,Tawfik O W,et al.Breast conservation therapy with tumor bed irradiation alone in a elected group of patients with stage I breast cancer.Breast J,2001,7(2):91-96.
[31]
Vicini F A,Baglan K L,Kestin L L,et al.Accelerated treatment of breast cancer.J Clin Oncol,2001,19:1993-2001.
[32]
Wazer D E,Berle L,Graham R,et al.Preliminary results of a phase Ⅰ/Ⅱ study of HDR brachytherapy alone for T1/T2 breast can cer.Int J Radiat Oncol Biol Phys,2002,53:889-897.
[33]
Polgar C,Sulyok Z,Fodor J,et al.Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer:five-year results of a phase Ⅰ-Ⅱ study and initial findings of a randomized phase Ⅲ trial.J Surg Oncol,2002,80:121-128.
[34]
Edmundson G K,Vicini F A,Chen P Y,et al.Dosimetric characteristics of the MammoSite RTS,a new breast brachytherapy applicator.Int J Radiat Oncol Biol Phys,2002,52:1132-1139.
[35]
Dickler A,Kirk M,Choo J,et al.Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.Int J Radiat Oncol Biol Phys,2004,59:469-474.
[36]
Kuerer H M,Julian T B,Strom E A,et al.Accelerated partial breast irradiation after conservative surgery for breast cancer.Ann Surg,2004,239:338-351.
[37]
Intra M,Gatti G,Luini A,et al.Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer.Arch Surg,2002,137:737-740.
[38]
Veronesi U,Gatti G,Luini A,et al.Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery.Arch Surg,2003,138:1253-1256.
[39]
Cuncins Hearn A,Saunders C,Walsh D,et al.A systemic review of intraoperative radiotherapy in early breast cancer.Breast Cancer Res Treat,2004,85:271-280.
[40]
Krueger E A,Fraass B A,Pierce L J.Clinical aspects of intensity-modulated radiotherapy in the treatment of breast cancer.Semin Radiat Oncol,2002,12:250-259.
[41]
Vicini F A,Remouchamps V,Wallace M,et al.Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer.Int J Radiat Oncol Biol Phys,2003,57:1247-1253.
[42]
Kurtz J.The curative role of radiotherapy in the treatment of operable breast cancer.Eur J Cancer,2002,38:1961-1974.
[43]
Kunkler I H.When may adjuvant radiotherapy be avoided in operable breast cancer?Clinical Oncology,2006,18:191-199.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 自动乳腺超声联合免疫组化早期预测乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(04): 361-369.
[3] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[4] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[5] 牛海刚, 郭文科. 三阴性乳腺癌组织中双特异性磷酸酶14与核受体相互作用蛋白1的表达及预后价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 199-205.
[6] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[7] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[8] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[9] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[10] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[11] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
阅读次数
全文


摘要